CLINICAL TRIALS OPERATIONS Release Date: May 11, 1999 RFP AVAILABLE: N01DA-9-8095 P.T. National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to conduct Phase I and II clinical trials of potential treatment drugs, both new and marketed, for the treatment of drug addiction. Specifically, treatment drugs for two classes of drugs of abuse (stimulants and opiates) will be investigated clinically under the current Food and Drug Administration regulations and Good Clinical Practice guidelines. The Contractor shall provide all the necessary services to conduct clinical trials. The offeror must be highly experienced in conducting clinical pharmacology, Phase I and II clinical trials in any therapeutic area. Due to the nature of the study compounds which will be evaluated under the contract, it is mandatory that offerors possess a Drug Enforcement Administration (DEA) Research Registration for Schedules II to V in order to handle substances under the Controlled Substances Act of 1970. NIDA anticipates a multiple award of four five-year task order type contracts as a result of this solicitation. RFP No. N01DA-9-8095 will be available electronically on or about May 19, 1999 and may be accessed through the NIDA website at URL: http://www.nida.nih.gov/RFP/RFPList.html. Responses to the RFP will be due approximately 45 calendar days thereafter. Please note that the RFP for this acquisition will be issued in a streamlined format which will include only the Work Statement, Deliverables and Reporting Requirements, Special Requirements and Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. All information required for the submission of a proposal will be contained in or accessible through the streamlined RFP package. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. INQUIRIES Point of Contact: Kenneth E. Goodling, Contracting Officer National Institute on Drug Abuse, NIH Contracts Management Branch, OPRM 6001 Executive Blvd., Room 3105, MSC 9543 Bethesda, Maryland 20892-9543 Electronic Mail Address: kg25d@nih.gov Telephone: (301) 443-6677 Fax: (301) 443-7595
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |